175 related articles for article (PubMed ID: 3331321)
81. Transdermal clonidine. A preliminary review of its pharmacodynamic properties and therapeutic efficacy.
Langley MS; Heel RC
Drugs; 1988 Feb; 35(2):123-42. PubMed ID: 3281820
[TBL] [Abstract][Full Text] [Related]
82. Duration of efficacy of anti-anginal drugs.
Nyberg GF
Lancet; 1992 Feb; 339(8788):307. PubMed ID: 1346309
[No Abstract] [Full Text] [Related]
83. [Nifedipine pharmacokinetics in patients with exertion-induced stenocardia after its single and long-term administration].
Rumiantsev DO; Piotrovskiĭ VK; Metelitsa VI; Riaboko'n OS; Slastnikova ID
Kardiologiia; 1989 May; 29(5):12-5. PubMed ID: 2770079
[TBL] [Abstract][Full Text] [Related]
84. An atenolol/nifedipine tablet for hypertension--useful or not?
Drug Ther Bull; 1989 Jun; 27(12):47-8. PubMed ID: 2519121
[No Abstract] [Full Text] [Related]
85. The comparative effects of clonidine hydrochloride and nifedipine in the treatment of hypertensive crises.
Houston MC
Am Heart J; 1988 Jan; 115(1 Pt 1):152-9. PubMed ID: 3276107
[No Abstract] [Full Text] [Related]
86. The USA experience with the clonidine transdermal therapeutic system.
Burris JF
Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
[TBL] [Abstract][Full Text] [Related]
87. A review of the gastrointestinal therapeutic system (GITS) formulation and its effectiveness in the delivery of antihypertensive drug treatment (focus on nifedipine GITS).
Meredith PA; Elliott HL
Integr Blood Press Control; 2013; 6():79-87. PubMed ID: 23901292
[TBL] [Abstract][Full Text] [Related]
88. Rate and extent of absorption of clonidine from a transdermal therapeutic system.
Toon S; Hopkins KJ; Aarons L; Rowland M
J Pharm Pharmacol; 1989 Jan; 41(1):17-21. PubMed ID: 2565958
[TBL] [Abstract][Full Text] [Related]
89. [Nifedipine in the treatment of diseases of the circulatory organs (a review of the literature)].
Revutskiĭ EL; Konopleva LF; Shevchuk SG
Vrach Delo; 1989 Nov; (11):62-7. PubMed ID: 2692292
[No Abstract] [Full Text] [Related]
90. Clinical acceptability of transdermal clonidine: a large-scale evaluation by practitioners.
Hollifield J
Am Heart J; 1986 Oct; 112(4):900-6. PubMed ID: 2945414
[No Abstract] [Full Text] [Related]
91. Steady-state kinetics of a fatty-alcohol based slow release nifedipine formulation in 60 mg, 90 mg and 120 mg dosages daily.
Merz PG; Rietbrock S; Pfleiderer S; Woodcock BG
Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):480-1. PubMed ID: 1490792
[No Abstract] [Full Text] [Related]
92. Dose linearity of clonidine after transdermal application.
Wallenstein G; Gladigau V
Clin Auton Res; 1993 Dec; 3(6):369-72. PubMed ID: 8193523
[TBL] [Abstract][Full Text] [Related]
93. [Clonidine and anesthesia].
González Machado JL; de Pascual Mettler I
Rev Esp Anestesiol Reanim; 1989; 36(2):119-23. PubMed ID: 2675217
[No Abstract] [Full Text] [Related]
94. [Hypokalemia caused by nifedipine].
Popiliev I; Angelova I; Kundurdzhiev A
Vutr Boles; 1990; 29(3):126-9. PubMed ID: 2284794
[TBL] [Abstract][Full Text] [Related]
95. How urgent is 'urgent' hypertension?
Ferguson RK; Vlasses PH
Arch Intern Med; 1989 Feb; 149(2):257-8. PubMed ID: 2916869
[No Abstract] [Full Text] [Related]
96. Old wine into new bottles. A critical evaluation of transdermal clonidine in the treatment of hypertension.
Mathias CJ
Clin Auton Res; 1993 Dec; 3(6):355. PubMed ID: 8193520
[No Abstract] [Full Text] [Related]
97. Pharmacokinetic comparison of a slow-release clonidine with a conventional formulation after acute and chronic administration in hypertensives.
Conway EL; Anavekar SN; Howes LG; Louis WJ
J Clin Pharmacol; 1992 May; 32(5):427-33. PubMed ID: 1587960
[TBL] [Abstract][Full Text] [Related]
98. Treatment of hypertensive out-patients with a sustained-release dosage form of clonidine: a comparison with standard tablet therapy and long-term follow-up study.
Steger W
Curr Med Res Opin; 1980; 6(10):670-6. PubMed ID: 7428405
[TBL] [Abstract][Full Text] [Related]
99. [Treatment of hypertension with hemiton and Brinaldix].
Panikarskiĭ VG
Vrach Delo; 1979 Feb; (2):27-9. PubMed ID: 371135
[No Abstract] [Full Text] [Related]
100. Sample sizes and withdrawals in clinical trials.
Caubet JF; Stason WB; Bishop DJ; Ross SD
Lancet; 1996 Sep; 348(9031):895. PubMed ID: 8826835
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
